Psychosocial correlates of fatigue in multiple sclerosis

Archives of Physical Medicine and Rehabilitation

Volumn 77, Issue 2, 1996, Pages 165-170

  Schwartz, Carolyn E ^a,b,c,d   Coulthard Morris, Linda ^a   Zeng, Qi ^e  

^a Rocky Mountain MS Center   (United States)

^b FRONTIER SCIENCE AND TECHNOLOGY RESEARCH FOUNDATION   (United States)

^c UNIVERSITY OF COLORADO   (United States)

^d BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^e HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT;

ADULT; ANXIETY NEUROSIS; ARTICLE; DEPRESSION; FATIGUE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NEUROPSYCHOLOGICAL TEST; PERFORMANCE; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; RATING SCALE; SOCIAL PSYCHOLOGY; WELLBEING;

EID: 0030031085     PISSN: 00039993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-9993(96)90162-8     Document Type: Article

References (43)

1. Monks J. Experiencing symptoms in chronic illness: fatigue in multiple sclerosis. Int Disabil Stud 1989;11:78-83.
2. Krupp LB, Alvarez LA, LaRocca NG, Scheinberg LC. Fatigue in multiple sclerosis. Arch Neurol 1988;45:435-7.
3. Murray TJ. Amantadine therapy for fatigue in multiple sclerosis. Can J Neurol Sci 1985;12:251-4.
4. Freal JE, Kraft GH, Coryell JK. Symptomatic fatigue in multiple sclerosis. Arch Phys Med Rehabil 1984;65:135-8.
5. Edgley K, Sullivan M, Dehoux E. A survey of multiple sclerosis: II. Determinants of employment status. Can J Rehabil 1991;4:127-32.
6. Jackson MF, Quaal C, Reeves MA. Effects of multiple sclerosis on occupational and career patterns. Axon 1991;Sept.:16-22.
7. Ivers RR, Goldstein NP. Multiple sclerosis: current appraisal of signs and symptoms. Mayo Clin Proc 1963;38:457-66.
8. Schapiro RT, Harris L, Lenling M, Metelak J. Fatigue. In: Schapiro RT, editor. Symptom Management in Multiple Sclerosis. New York: Demos Publications, 1987.
9. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders-Revised. Washington, DC: American Psychiatric Association, 1987.
10. The Canadian Research Group. A randomized controlled trial of amantadine in fatigue associated with multiple sclerosis. Can J Neurol Sci 1987;14:273-8.
11. Cohen RA, Fisher M. Amantadine treatment of fatigue associated with multiple sclerosis. Arch Neurol 1989;46:676-80.
12. Scheinberg L, Holland N, LaRocca N, Laitin P, Bennett A, Hall H. Multiple sclerosis: earning a living. NY State J Med 1980;80:1395-400.
13. Weinshenker BG, Penman M, Bass B, Ebers GC, Rice GPA. A double-blind, randomized, crossover trial of pemoline in fatigue associated with multiple sclerosis. Neurology 1992;42:1468-71.
14. Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD. The fatigue severity scale: application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 1989;46:1121-3.
15. Amato M, Fratiglioni L, Groppi C, Siracusa G, Amaducci L. Interrater reliability in assessing functional systems and disability on the Kurtzke scale in multiple sclerosis. Arch Neurol 1988;45:746-8.
16. Noseworthy JH, Vandervoort MK, Wong CJ, Ebers GC, and the Canadian Cooperative MS Study Group. Interrater variability with the Expanded Disability Status Scale (EDSS) and Functional Systems (FS) in a multiple sclerosis clinical trial. Neurology 1990;40:971-5.
17. Pepper CM, Krupp LB, Friedberg F, Doscher C, Coyle PK. A comparison of neuropsychiatric characteristics in chronic fatigue syndrome, multiple sclerosis and major depression. J Neuropsychiatry Clin Neurosci 1993;5:200-5.
18. Minden SL, Moes EJ, Orav J, Kaplan E, Reich P. Memory impairment in multiple sclerosis. J Clin Exp Neuropsychol 1990;12:566-86.
19. Van den Berg W, Van Zomeren AH, Minderhoud JM, Prange AJA, Meijer NSA. Cognitive impairment in patients with multiple sclerosis and mild physical disability. Arch Neurol 1987;44:494-501.
20. Sandroni P, Walker C, Starr A. "Fatigue" in patients with multiple sclerosis: motor pathway conduction and event-related potentials. Arch Neurol 1992;49:517-24.
21. Jennekens-Schinkel A, Sanders EACM, Lanser JBK, Van der Velde EA. Reaction time in ambulant multiple sclerosis patients, I: influence of prolonged cognitive effort. J Neurol Sci 1988;85:173-86.
22. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;33:1444-52.
23. Schwartz CE, Rogers M. Designing a psychosocial intervention to teach coping flexibility. Rehabilitation Psychology 1994;39(1):61-76.
24. Belza BL, Henke CJ, Yelin EH, Epstein WV, Gilliss CL. Correlates of fatigue in older adults with rheumatoid arthritis. Nurs Res 1993;42:93-9.
25. Rao SM, Leo GJ, Haughton VM, Aubin-Faubert P, Bernardin L. Correlation of magnetic resonance imaging with neuropsychological testing in multiple sclerosis. Neurology 1989;39:161-6.
26. Rao SM, Leo G, Bernardin L, Unverzagt F. Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction. Neurology 1991a;41:685-91.
27. Rao SM, Leo G, Ellington L, Nauertz T, Bernardin L, Unverzagt F. Cognitive dysfunction in multiple sclerosis. II. Impact on employment and social functioning. Neurology 1991b;41:692-6.
28. Army Individual Test Battery. Manual of Directions and Scoring. Washington, DC: War Department, Adjutant General's Office, 1944.
29. Buschke H, Fuld PA. Evaluating storage, retention, and retrieval in disordered memory and learning. Neurology 1974;24:1019-25.
30. Smith A. Symbol Digit Modalities Test (revised). Los Angeles: Western Psychological Services, 1982.
31. Reitan R. Validity of the Trail-Making Test as an indication of organic brain damage. Perceptual Motor Skills 1958;8:271-6.
32. Pollard WE, Bobbitt RA, Bergner M, Martin DP, Gilson BS. The Sickness Impact Profile: reliability of a health status measure. Medical Care 1976;14:146-55.
33. Bergner M, Bobbitt RA, Carter WB, Gilson BS. The Sickness Impact Profile: development and final revision of a health status measure. Medical Care 1981;19:787-805.
34. Meenan RF, Gertman PM, Mason JM. Measuring health status in arthritis: the Arthritis Impact Measurement Scales. Arthritis Rheum 1980;23:146-52.
35. McDowell I, Newell C. Measuring health. A guide to rating scale and questionnaires. New York: Oxford University Press, 1987.
36. Ryff CD. Happiness is everything, or is it? Explorations on the meaning of psychological well-being. J Pers Soc Psychol 1989;57:1069-81.
37. Schwartz CE, Fox BH. Who says yes? Identifying selection biases in a psychosocial intervention study of multiple sclerosis. Soc Sci Med 1995;40(3):359-70.
38. Confavreux C, Aimard G, Devic M. Course and prognosis of multiple sclerosis assessed by the computerized data processing of 349 patients. Brain 1980;103:281-300.
39. Matthews WB, Compston A, Allen IV, Martyn CN. McAlpine's multiple sclerosis. 2nd ed. New York: Churchill Livingstone, 1991.
40. Minden SL, Marder WD, Harrold LN, Dor A. Multiple sclerosis: a statistical portrait. New York: National Multiple Sclerosis Society, 1993.
41. Foley FW, Bedell JR, LaRocca NG, Scheinberg LC. Efficacy of stress-inoculation training in coping with multiple sclerosis. J Consult Clin Psychol 1987;55:919-22.
42. Fischer JS, Foley FW, Aikens JE, Ericson GD, Rao SM, Shindell S. What do we really know about cognitive dysfunction, affective disorders, and stress in multiple sclerosis? A practitioner's guide. J Neurol/Rehabil 1994;8:151-64.
43. Wexler BE, Cicchetti DV. The outpatient treatment of depression: implications of outcome research for clinical practice. J Nerv Ment Dis 1992;180:277-86.